EMVision Medical Devices Ltd (EMV.AX)
AUD 1.84
(-2.13%)
AUD 1.84
(-2.13%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 | 5.45 Million AUD | -14.79% |
| 2023 | 6.4 Million AUD | 349.1% |
| 2022 | 1.42 Million AUD | 98.0% |
| 2021 | 720 Thousand AUD | 47.02% |
| 2020 | 489.72 Thousand AUD | 6.45% |
| 2019 | 460.05 Thousand AUD | 37.08% |
| 2018 | 335.6 Thousand AUD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q4 | 5.45 Million AUD | 0.0% |
| 2024 Q2 | 5.52 Million AUD | 0.0% |
| 2024 FY | 5.45 Million AUD | -14.79% |
| 2023 FY | 6.4 Million AUD | 349.1% |
| 2023 Q2 | 3.22 Million AUD | 0.0% |
| 2023 Q4 | 6.4 Million AUD | 0.0% |
| 2022 FY | 1.42 Million AUD | 98.0% |
| 2022 Q2 | 1 Million AUD | 0.0% |
| 2022 Q4 | 1.42 Million AUD | 0.0% |
| 2021 Q2 | 1.23 Million AUD | 0.0% |
| 2021 FY | 720 Thousand AUD | 47.02% |
| 2021 Q4 | 720 Thousand AUD | 0.0% |
| 2020 Q2 | 432.6 Thousand AUD | 0.0% |
| 2020 FY | 489.72 Thousand AUD | 6.45% |
| 2020 Q4 | 489.72 Thousand AUD | 0.0% |
| 2019 Q3 | 460.05 Thousand AUD | -23.2% |
| 2019 Q2 | 598.99 Thousand AUD | 0.0% |
| 2019 FY | 460.05 Thousand AUD | 37.08% |
| 2019 Q4 | 460.05 Thousand AUD | 0.0% |
| 2018 Q4 | 335.61 Thousand AUD | 0.0% |
| 2018 FY | 335.6 Thousand AUD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| 4DMedical Limited | 49.08 Million AUD | 88.886% |
| Adherium Limited | 3.4 Million AUD | -60.142% |
| Aroa Biosurgery Limited | 14.77 Million AUD | 63.084% |
| Atomo Diagnostics Limited | 1.29 Million AUD | -321.484% |
| Anteris Technologies Ltd | 17.03 Million AUD | 67.982% |
| Control Bionics Limited | 2.75 Million AUD | -97.697% |
| CardieX Limited | 8.56 Million AUD | 36.283% |
| Compumedics Limited | 22.14 Million AUD | 75.367% |
| Cochlear Limited | 904.6 Million AUD | 99.397% |
| CleanSpace Holdings Limited | 6.94 Million AUD | 21.498% |
| Cyclopharm Limited | 13.65 Million AUD | 60.046% |
| Nova Eye Medical Limited | 8.55 Million AUD | 36.206% |
| HeraMED Limited | 1.5 Million AUD | -262.277% |
| Imricor Medical Systems, Inc. | 25 Million AUD | 78.181% |
| ImpediMed Limited | 6.24 Million AUD | 12.612% |
| InhaleRx Limited | 911.41 Thousand AUD | -498.594% |
| LBT Innovations Limited | 5.5 Million AUD | 0.95% |
| Micro-X Limited | 12.63 Million AUD | 56.818% |
| Neurotech International Limited | 314.69 Thousand AUD | -1633.612% |
| OncoSil Medical Limited | 1.98 Million AUD | -175.261% |
| PolyNovo Limited | 37.04 Million AUD | 85.272% |
| Respiri Limited | 3.55 Million AUD | -53.509% |
| SomnoMed Limited | 24.78 Million AUD | 77.984% |
| Universal Biosensors, Inc. | 10.61 Million AUD | 48.592% |
| Uscom Limited | 2.07 Million AUD | -163.104% |
| Visioneering Technologies, Inc. | 2.76 Million AUD | -97.175% |